Investor Whitefort Capital Master Fund, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Whitefort Capital Master Fund, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2026-04-28 13D/A ABUS / Arbutus Biopharma Corporation 15,794,261 15,794,261
2026-04-13 13D/A ABUS / Arbutus Biopharma Corporation 13,307,967 15,794,261
2025-02-21 13D/A ABUS / Arbutus Biopharma Corporation 12,867,967 13,307,967
2023-02-14 13G/A MTBL / Moatable, Inc. - Depositary Receipt (Common Stock) 1,048,194 0
2023-02-14 13G/A SRAX / SRAX, Inc. 1,713,410 16,736
2022-02-03 13G SRAX / SRAX, Inc. 1,713,410
2021-12-23 13G RENN / Renren Inc - ADR 1,048,194
2021-02-16 13G/A TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock) 1,190,012 585,570
2021-02-16 13G/A SCPL / Sciplay Corp - Class A 1,224,860 0
2021-02-16 13G/A GSL / Global Ship Lease, Inc. 883,041 822,270
2020-03-20 13G SCPL / Sciplay Corp - Class A 1,224,860
2020-03-13 13G GSL / Global Ship Lease, Inc. 883,041
2020-03-13 13G AKRX / Akorn, Inc. 6,388,120
2020-02-14 13G/A NIHD / NII Holdings, Inc. 5,481,174 0
2020-02-14 13G/A MTEC / MTech Acquisition Corp. 360,000 0
2019-09-27 13D/A NVLN / NOVELION THERAPEUTICS INC. 1,886,230 286,230
2019-07-01 13G NIHD / NII Holdings, Inc. 5,481,174
2019-06-20 13D/A NVLN / NOVELION THERAPEUTICS INC. 1,886,230 1,886,230
2019-05-24 13D/A NVLN / NOVELION THERAPEUTICS INC. 1,582,341 1,886,230
2019-05-03 13G TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock) 1,190,012
2019-04-02 13D/A NVLN / NOVELION THERAPEUTICS INC. 1,582,341 1,582,341
2019-03-29 13D NVLN / NOVELION THERAPEUTICS INC. 0 1,582,341
2019-02-14 13G/A NVLN / NOVELION THERAPEUTICS INC. 1,035,275 0
2018-10-26 13G MTEC / MTech Acquisition Corp. 360,000
2018-08-23 13G NVLN / NOVELION THERAPEUTICS INC. 1,035,275